OXYN-AVENIR 105 mg Israel - English - Ministry of Health

oxyn-avenir 105 mg

bioavenir ltd, israel - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - tablets prolonged release - oxycodone hydrochloride 10 mg; naloxone hydrochloride (as dihydrate) 5 mg - oxycodone and naloxone - indicated for the relief of moderate to severe pain. the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.

OXYN-AVENIR 2010 mg Israel - English - Ministry of Health

oxyn-avenir 2010 mg

bioavenir ltd, israel - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - tablets prolonged release - oxycodone hydrochloride 20 mg; naloxone hydrochloride (as dihydrate) 10 mg - oxycodone and naloxone - indicated for the relief of moderate to severe pain. the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.

OXYN-AVENIR 3015mg Israel - English - Ministry of Health

oxyn-avenir 3015mg

bioavenir ltd, israel - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - tablets prolonged release - oxycodone hydrochloride 30 mg; naloxone hydrochloride (as dihydrate) 15 mg - oxycodone and naloxone - indicated for the relief of moderate to severe pain. the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.

OXYN-AVENIR 4020 mg Israel - English - Ministry of Health

oxyn-avenir 4020 mg

bioavenir ltd, israel - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - tablets prolonged release - oxycodone hydrochloride 40 mg; naloxone hydrochloride (as dihydrate) 20 mg - oxycodone and naloxone - indicated for the relief of moderate to severe pain. the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.

OXYN-AVENIR 52.5 mg Israel - English - Ministry of Health

oxyn-avenir 52.5 mg

bioavenir ltd, israel - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - tablets prolonged release - oxycodone hydrochloride 5 mg; naloxone hydrochloride (as dihydrate) 2.5 mg - oxycodone and naloxone - indicated for the relief of moderate to severe pain. the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.

OXYCODONE HCl 10 mg/1 mL MEDSURGE oxycodone hydrochloride 10 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone hcl 10 mg/1 ml medsurge oxycodone hydrochloride 10 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium citrate dihydrate; hydrochloric acid; citric acid monohydrate; sodium chloride; sodium hydroxide; water for injections - oxycodone hcl medsurge solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE HCl 20 mg/2 mL MEDSURGE oxycodone hydrochloride 20 mg/2 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone hcl 20 mg/2 ml medsurge oxycodone hydrochloride 20 mg/2 ml solution for injection ampoule

medsurge pharma pty ltd - oxycodone hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: citric acid monohydrate; sodium chloride; water for injections; sodium hydroxide; hydrochloric acid; sodium citrate dihydrate - oxycodone hcl medsurge solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE HCl 50 mg/1 mL MEDSURGE oxycodone hydrochloride 50 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone hcl 50 mg/1 ml medsurge oxycodone hydrochloride 50 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - oxycodone hydrochloride, quantity: 50 mg/ml - injection, solution - excipient ingredients: citric acid monohydrate; sodium chloride; hydrochloric acid; sodium hydroxide; sodium citrate dihydrate; water for injections - oxycodone hcl medsurge solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE-HAMELN oxycodone hydrochloride 50 mg/1 mL injection solution ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone-hameln oxycodone hydrochloride 50 mg/1 ml injection solution ampoule

hameln pharma pty ltd - oxycodone hydrochloride, quantity: 50 mg - injection, solution - excipient ingredients: citric acid monohydrate; hydrochloric acid; sodium citrate dihydrate; water for injections; sodium hydroxide; sodium chloride - oxycodone-hameln solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE-HAMELN oxycodone hydrochloride 10 mg/1 mL injection solution ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone-hameln oxycodone hydrochloride 10 mg/1 ml injection solution ampoule

hameln pharma pty ltd - oxycodone hydrochloride, quantity: 10 mg - injection, solution - excipient ingredients: sodium citrate dihydrate; sodium hydroxide; sodium chloride; hydrochloric acid; water for injections; citric acid monohydrate - oxycodone-hameln solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.